What does CUSIP 86150R107 represent in this 13F holders report?

CUSIP 86150R107 is the security identifier for STOK - Stoke Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held STOK - Stoke Therapeutics, Inc. - Common Stock in Q4 2019?

64 institutional investors reported STOK - Stoke Therapeutics, Inc. - Common Stock for Q4 2019. Use the holders table for investor-level position and value details.

Stoke Therapeutics, Inc. - Common Stock (STOK)

CUSIP: 86150R107

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / Common Stock
Shares outstanding: 57,529,259
Total 13F shares: 33,483,529
Share change: +752,167
Total reported value: $948,191,901
Price per share: $28.32
Number of holders: 64
Value change: +$22,388,802
Number of buys: 38
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 86150R107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	5.8%	3,355,466	$69,401,000	—	30 Sep 2019	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	3.3%	1,876,191	$40,319,000	—	30 Sep 2019	13F
Cormorant Asset Management, LP	13F	Company	3.1%	1,788,394	$38,433,000	—	30 Sep 2019	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.9%	1,119,963	$24,068,000	—	30 Sep 2019	13F
JANUS HENDERSON GROUP PLC	13F	Company	2%	1,144,575	$23,875,000	—	30 Sep 2019	13F
Redmile Group, LLC	13F	Company	1.8%	1,017,478	$21,866,000	—	30 Sep 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.2%	697,811	$14,995,000	—	30 Sep 2019	13F
VANGUARD GROUP INC	13F	Company	1.2%	673,584	$14,476,000	—	30 Sep 2019	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.2%	671,978	$14,440,000	—	30 Sep 2019	13F
BlackRock Finance, Inc.	13F	Company	1.1%	618,760	$13,298,000	—	30 Sep 2019	13F
FEDERATED HERMES, INC.	13F	Company	1%	576,000	$12,378,000	—	30 Sep 2019	13F
FMR LLC	13F	Company	0.77%	443,013	$9,520,000	—	30 Sep 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.66%	382,313	$8,216,000	—	30 Sep 2019	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.6%	346,380	$7,384,000	—	30 Sep 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.25%	144,923	$3,115,000	—	30 Sep 2019	13F
STATE STREET CORP	13F	Company	0.24%	138,979	$2,987,000	—	30 Sep 2019	13F
Casdin Capital, LLC	13F	Company	0.23%	130,000	$2,793,700	—	30 Sep 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.2%	116,196	$2,497,000	—	30 Sep 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	112,752	$2,423,000	—	30 Sep 2019	13F
NORTHERN TRUST CORP	13F	Company	0.19%	107,896	$2,319,000	—	30 Sep 2019	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.15%	88,755	$1,907,000	—	30 Sep 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	52,354	$1,126,000	—	30 Sep 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	46,187	$993,000	—	30 Sep 2019	13F
NORGES BANK	13F	Company	0.04%	25,000	$537,000	—	30 Sep 2019	13F
Zimmer Partners, LP	13F	Company	0.04%	25,000	$537,000	—	30 Sep 2019	13F
Bank of New York Mellon Corp	13F	Company	0.04%	24,595	$529,000	—	30 Sep 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.04%	23,399	$503,000	—	30 Sep 2019	13F
Squarepoint Ops LLC	13F	Company	0.04%	21,699	$466,000	—	30 Sep 2019	13F
TD ASSET MANAGEMENT INC	13F	Company	0.03%	19,879	$427,000	—	30 Sep 2019	13F
Granite Point Capital Management, L.P.	13F	Company	0.03%	17,000	$365,000	—	30 Sep 2019	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.03%	16,849	$362,000	—	30 Sep 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	14,264	$307,000	—	30 Sep 2019	13F
Athanor Capital, LP	13F	Company	0.02%	14,200	$305,000	—	30 Sep 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	13,900	$299,000	—	30 Sep 2019	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.02%	12,000	$258,000	—	30 Sep 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	9,600	$206,000	—	30 Sep 2019	13F
UBS Group AG	13F	Company	0.01%	6,074	$131,000	—	30 Sep 2019	13F
MORGAN STANLEY	13F	Company	0.01%	6,040	$130,000	—	30 Sep 2019	13F
BARCLAYS PLC	13F	Company	0.01%	6,001	$129,000	—	30 Sep 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	5,780	$124,000	—	30 Sep 2019	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.01%	3,913	$84,000	—	30 Sep 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	3,714	$79,000	—	30 Sep 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	3,441	$74,000	—	30 Sep 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	3,001	$64,000	—	30 Sep 2019	13F
DEUTSCHE BANK AG\	13F	Company	0%	2,825	$59,000	—	30 Sep 2019	13F
STRS OHIO	13F	Company	0%	2,400	$51,000	—	30 Sep 2019	13F
Legal & General Group Plc	13F	Company	0%	1,490	$32,000	—	30 Sep 2019	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	1,158	$24,885	—	30 Sep 2019	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0%	1,000	$21,000	—	30 Sep 2019	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	761	$16,000	—	30 Sep 2019	13F

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q4 2019

As of 31 Dec 2019, Stoke Therapeutics, Inc. - Common Stock (STOK) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,483,529 shares. The largest 10 holders included Apple Tree Partners IV, L.P., RTW INVESTMENTS, LP, GILDER GAGNON HOWE & CO LLC, Cormorant Asset Management, LP, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, Redmile Group, LLC, BlackRock Inc., FEDERATED HERMES, INC., and VANGUARD GROUP INC. This page lists 64 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 Value $	Q4 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.